Last updated on: 25/06/2014
1. Contact details
This data source is maintained by the following centre registered in the ENCePP inventory of research centres: IADB.NL
Name of data sourceIADB
Name under which the data source should be displayed in the inventory (e.g short name if one exists)IADB
Name of organisation
1) Department/research groupIADB.NL
2) Organisation/affiliationUniversity of Groningen
Administrative Contact
Title Mr
Last name Bos
First name Jens
Address line 1Antonius Deusinglaan 1
Address line 2Department of PharmacoEpidemiology and PharmacoEconomics
Address line 3
CityGroningen
Postcode9713 AV
CountryNetherlands
Scientific Contact
Title Professor
Last name Hak
First name Eelko
Address line 1Antonius Deusinglaan 1
Address line 2Department of PharmacoEpidemiology and PharmacoEconomics
Address line 3
CityGroningen
Postcode9713 AV
CountryNetherlands
2. Description/category
Pharmacy dispensing database
3.1 Coverage of licensed medicinal products
Licensed Medicinal Product
Comments
Prescription data from community pharmacies
3.2 ATC code (5th level)
Yes
3.3 Other product dictionaries
G-standaard
3.4 Recording of indication for use
No
4. Coverage of events
Event
Dictionary
Dictionary details
No events
5. Year of establishment
1994
6. Geographical origin of data
EEA/EFTA countries
Netherlands
7. Demographical extent of data collection
Regional sub-set :
The Northern and Eastern part of the country, but representative for the whole of the Netherlands
8. Age groups
17 years and under [Paediatrics]
term newborn infants (0 to 27 days)
infants and toddlers (28 days to 23 months)
children (2 to 11 years)
adolescents (12 to 17 years)
18 to 45 years
46 to 64 years
65 years and over
65 to 75 years
76 years and over
9. Size of the source/catchment population
600,772
10 a. Total (cumulative) number of persons with actual data
1,457,949
10 b. Number of persons with active data collection in past calendar year
470,564
11. Possibility to obtain additional information on the patient
a) Clinical information from treating physician?
No
b) Questionnaire data from the patient?
No
c) Genetic information or samples?
No
12. Possibility of links to other sources of data
Yes :
Generic linking to other data sources
13. Written policy governing data access
Yes
14. Committee to evaluate requests for data access
Yes
15. Charge/fee for data access
Yes
Special arrangements for academic purposes:
Yes
16. Selected publications of the last 5 calendar years using data from this data source
ReferenceLink to web-publication
Baseline albuminuria predicts
the efficacy of blood
pressure-lowering drugs in
preventing cardiovascular
events
Cornelis Boersma, Maarten J. Postma, Sipke T. Visser, Jarir Atthobari,
Paul E. de Jong,1 Lolkje T. W. de Jong-van den Berg &
Ron T. Gansevoort1 on behalf of the PREVEND Study Group
Excess drug prescriptions during influenza and RSV seasons in the Netherlands:
Potential implications for extended influenza vaccination
M.D.M. Assink,1, J.P. Kiewiet,1, M.H. Rozenbaum,∗,1, P.B. Van den Berga E. Hak,
E.J. Buskens, J.C. Wilschut, A.C.M. Kroese, M.J. Postma
Excess drug prescriptions during influenza and RSV seasons in the Netherlands:
Potential implications for extended influenza vaccination
M.D.M. Assink,1, J.P. Kiewiet,1, M.H. Rozenbauma,∗, P.B. Van den Berg, E. Hak,
E.J. Buskens, J.C. Wilschut, A.C.M. Kroese, M.J. Postma,
Clomiphene citrate utilization
in the Netherlands 1998–2007
H. Wang,*, J.A. Land, H.J. Bos, M.K. Bakker,
and L.T.W. de Jong-van den Berg
